Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Chronic inflammatory skin diseases: From pathogenesis to treatment
Clinical, Cosmetic and Investigational Dermatology
ISSN: 1178-7015
- View all (1717)
- Volume 17, 2024 (142)
- Volume 16, 2023 (410)
- Volume 15, 2022 (317)
- Volume 14, 2021 (200)
- Volume 13, 2020 (114)
- Volume 12, 2019 (107)
- Volume 11, 2018 (75)
- Volume 10, 2017 (62)
- Volume 9, 2016 (54)
- Volume 8, 2015 (71)
- Volume 7, 2014 (37)
- Volume 6, 2013 (37)
- Volume 5, 2012 (27)
- Volume 4, 2011 (28)
- Volume 3, 2010 (16)
- Volume 2, 2009 (17)
- Volume 1, 2008 (3)
Journal Articles:
- Chronic inflammatory skin diseases: From pathogenesis to treatment (1)
- Hidradenitis Suppurativa: Insights from pathogenesis to treatment (3)
- Teledermatology, Inflammatory Skin Disorders and COVID-19: What the Experience Has Taught Us (3)
- Hyaluronic acid fillers: superficial injections vs tridimensional injections, what changes? (2)
Chronic inflammatory skin diseases: From pathogenesis to treatment
Significant progress has been achieved in the last few decades in dermatology, especially regarding chronic inflammatory skin diseases. In recent years, great progress has also been made in understanding the pathogenesis of the most common inflammatory skin diseases such as psoriasis, atopic dermatitis, and hidradenitis suppurativa that has led to the development of selective and targeted innovative therapies. In particular, biological drugs (chimeric, humanized, and fully human monoclonal antibodies), biosimilars, and small molecules have completely revolutionized the treatment of chronic inflammatory skin diseases by opening new avenues for clinicians.
Secukinumab for Severe Hidradenitis Suppurativa in a Patient on Haemodialysis: Efficacy and Safety on 300 mg Every 2 Weeks Administration – A Case Report
Martora F, Annunziata MC, Potestio L, Battista T, Ruggiero A, Megna M
Clinical, Cosmetic and Investigational Dermatology 2024, 17:1275-1279
Published Date: 30 May 2024